tirzepatide health canada approval approves Mounjaro® (tirzepatide) for use in children 10 years and older living with type 2 diabetes FDA Grants Tirzepatide a New
Description
The other creates gastrointestinal problems
The prescribing information does not explicitly say "no alcohol." Your doctor might have glossed over it
Cutting corners on synthesis, using lower-grade reagents, or simply mislabeling other compounds are all possibilities
Check your vial label every time
The only valid comparison is clinical outcome (weight loss, appetite suppression, blood sugar control), not milligram dose
